Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma

被引:18
|
作者
Tan, Ying [1 ]
Li, Bijuan [1 ]
Peng, Fang [2 ]
Gong, Guanghui [3 ]
Li, Ning [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Blood Transfus, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, NHC Key Lab Canc Prote, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
基金
中国国家自然科学基金;
关键词
sirtuins; epigenetics; TCGA; cancer; clear cell renal cell carcinoma; TUMOR-SUPPRESSOR; CANCER; EXPRESSION; SIRT6; SURVIVAL; PROLIFERATION; RESISTANCE; GROWTH;
D O I
10.3389/fonc.2020.00218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sirtuins, class III histone deacetylases, are involved in multiple biological processes in cancer initiation and progression. However, the diverse expression patterns and prognostic values of sirtuins in cancers have yet to be elucidated. In this study, we first evaluated the expression and prognostic values of sirtuins in multiple cancer cohorts using publicly available TCGA pan-cancer datasets. Pan-cancer survival analysis indicated that 6 out of 7 sirtuin family members were significant associated with prognosis of clear cell renal cell carcinoma (KIRC) patients. SIRT1, SIRT3, SIRT4, and SIRT5 were associated with favorable prognosis of KIRC patients, while SIRT6 and SIRT7 were associated with unfavorable prognosis. The expression levels of SIRT4 and SIRT5 in KIRC tissues were lower than that in normal tissues, while SIRT6 and SIRT7 were higher in KIRC tissues. The expression levels of SIRT1, SIRT3, SIRT5, SIRT6, and SIRT7 were significantly correlated with tumor stage and histological grade. DNA methylation may contribute to the dysregulation of sirtuins. Finally, GSEA was conducted to predict the potential functions of sirtuins in KIRC. Our results may provide novel insights for the development of sirtuins-based cancer therapy in KIRC.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma
    Delahunt, B
    Bethwaite, PB
    Thornton, A
    BRITISH JOURNAL OF UROLOGY, 1997, 80 (03): : 401 - 404
  • [32] Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma
    Girgis, Hala
    Masui, Olena
    White, Nicole M. A.
    Scorilas, Andreas
    Rotondo, Fabio
    Seivwright, Annetta
    Gabril, Manal
    Filter, Emily R.
    Girgis, Andrew H. A.
    Bjarnason, Georg A.
    Jewett, Michael A. S.
    Evans, Andrew
    Al-Haddad, Sahar
    Siu, K. W. Michael
    Yousef, George M.
    MOLECULAR CANCER, 2014, 13
  • [33] Construction and validation of programmed cell death-based molecular clusters for prognostic and therapeutic significance of clear cell renal cell carcinoma
    Tang, Yanlin
    Zhang, Changzheng
    Ye, Chujin
    Tian, Kaiwen
    Zeng, Jiayi
    Cheng, Shouyu
    Zeng, Weinan
    Yang, Bowen
    Liu, Yanjun
    Yu, Yuming
    HELIYON, 2023, 9 (05)
  • [34] Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma
    Cho, Dae Sung
    Kim, Sun Il
    Choo, Seol Ho
    Jang, Seok Heun
    Ahn, Hyun Soo
    Kim, Se Joong
    SCANDINAVIAN JOURNAL OF UROLOGY, 2016, 50 (03) : 186 - 191
  • [35] A Bioinformatic Analysis of Immune-Related Prognostic Genes in Clear Cell Renal Cell Carcinoma Based on TCGA and GEO Databases
    Li, Jianpeng
    Cao, Jinlong
    Li, Pan
    Deng, Ran
    Yao, Zhiqiang
    Ying, Lijun
    Tian, Junqiang
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 325 - 342
  • [36] Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
    Zhang, Yan
    Chen, Mingying
    Liu, Meihong
    Xu, Yingkun
    Wu, Guangzhen
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [37] ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma
    Zhang, Chiyu
    Hu, Honglin
    Huang, Ruizhen
    Huang, Gaomin
    Xi, Xiaoqing
    FRONTIERS IN SURGERY, 2022, 9
  • [38] Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma
    Roldan, Fiorella L.
    Lozano, Juan J.
    Ingelmo-Torres, Mercedes
    Carrasco, Raquel
    Diaz, Esther
    Ramirez-Backhaus, Miguel
    Rubio, Jose
    Reig, Oscar
    Alcaraz, Antonio
    Mengual, Lourdes
    Izquierdo, Laura
    CANCERS, 2021, 13 (24)
  • [39] Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
    Larrinaga, Gorka
    Solano-Iturri, Jon Danel
    Errarte, Peio
    Unda, Miguel
    Loizaga-Iriarte, Ana
    Perez-Fernandez, Amparo
    Echevarria, Enrique
    Asumendi, Aintzane
    Manini, Claudia
    Angulo, Javier C.
    Lopez, Jose I.
    CANCERS, 2021, 13 (04) : 1 - 17
  • [40] Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy
    Xiang, Zhenfei
    Shen, Erdong
    Li, Mingyao
    Hu, Danfei
    Zhang, Zhanchun
    Yu, Senquan
    BIOENGINEERED, 2021, 12 (01) : 1773 - 1790